TITLE

Troubled Region

AUTHOR(S)
Olson, Parmy
PUB. DATE
May 2011
SOURCE
Forbes Asia;May2011, Vol. 7 Issue 6, p42
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that due to weak growth in sales and assets in Europe, there are only 14 European firms on The Global 2000 list of 2011. The sovereign-debt crisis in troubled nations like Greece, Ireland and Portugal had also an impact on the performance of European firms. The article also presents information on firms including Volkswagen Group, Deutsche Postbank, and Warner Chilcott PLC.
ACCESSION #
60897627

 

Related Articles

  • Warner Chilcott's P&G Buy Was a Balm for PE. Holman, Kelly // Investment Dealers' Digest;1/29/2010, Vol. 76 Issue 4, p23 

    The article announces the Warner Chilcott Ltd. acquisition of Procter & Gamble Co. global pharmaceuticals business was recognized as Private-Equity Deal of the Year from "Investment Dealers' Digest."

  • Francisco Rodríguez Rama lauds team as key to Warner Chilcott's success. DÍAZ, MARIO BELAVAL // Caribbean Business;4/10/2014, Vol. 42 Issue 13, p54 

    The article presents information related to Francisco Rodríguez Rama, technical operations vice president for Warner Chilcott PLC' operations in the municipalities of Fajardo and ManatI. It is noted that the fair share of international transfers typical of the life of executives in...

  • Bidding War Rages for UK Company. Houlton, Sarah // Pharmaceutical Executive;Dec2004, Vol. 24 Issue 12, p24 

    Reports on the issue regarding the bidding problem for the sale of pharmaceutical company Warner Chilcott PLC in Great Britain. Rivalry among investment companies; Expectation for company executives to contribute to the complexity of the transaction; Amount expected to be paid out to executive...

  • P&G Hones Focus.  // MMR;9/7/2009, Vol. 26 Issue 14, p13 

    The article reports on the agreement of Procter & Gamble Co. (P&G) to sell its global pharmaceuticals business to Warner Chilcott PLC. Under the deal, Warner Chilcott is expected to acquire the portfolio of its prescription products and its prescription drug pipeline and manufacturing facilities...

  • New name.  // Drug Topics;7/22/96, Vol. 140 Issue 14, p21 

    Announces the change in the name of Nale Laboratories PLC which is now known as Warner Chilcott Laboratories PLC.

  • Warner Chilcott Public Limited Company, SWOT Analysis.  // Warner Chilcott Ltd. SWOT Analysis;Oct2012, p1 

    A business analysis of Warner Chilcott PLC, a leading provider of branded prescription pharmaceutical products in gastroenterology, women's healthcare, dermatology and urology segment, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company....

  • Warner Chilcott Public Limited Company SWOT Analysis.  // Warner Chilcott Ltd. SWOT Analysis;Sep2012, p1 

    A business analysis of Warner Chilcott Public Ltd. Co., a pharmaceutical company, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include its expertise in life cycle management focus on selected therapeutics. Weaknesses...

  • Warner Chilcott Public Limited Company SWOT Analysis.  // Warner Chilcott Ltd. SWOT Analysis;Nov2012, p1 

    A business analysis of Warner Chilcott PLC, which is a provider of branded pharmaceutical drugs, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include benefits derived from its selective therapeutics. Weaknesses include...

  • Warner Chilcott Public Limited Company SWOT Analysis.  // Warner Chilcott Ltd. SWOT Analysis;Jun2013, p1 

    A business analysis of Warner Chilcott PLC, which is a specialty pharmaceutical company, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include its focus in selected therapeutic areas maximizes growth. Weaknesses include...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics